Here's a different Spin as at Dec'1st...
Acrux
The biotech has been a poor performer as investors fret about the slower than expected adoption rate of its testosterone treatment in the US and a fierce competitive response from market leader Abbott Laboratories.
These fears sent the stock crashing 40 per cent after it hit a record high of $4.76 in June this year, but the selling is overdone given the clear advantage of the Acrux treatment.
Management also went to great pains to point out that Cialis, an earlier treatment, needed five years to capture around a 50 per cent share of the erectile dysfunction market from Viagra.
Analysts have also forecast improved royalty payment streams with the sale of the treatment in other key markets such as Canada and Europe.
Just about all brokers are urging investors to buy the stock as its target price is nearly double where it is presently trading.
Macca's Neutral = Dunno ??? Anyhow, the chart
suggests it's been tough shortening this of late.
- Forums
- ASX - By Stock
- ACR
- macquarie goes negative on acr
macquarie goes negative on acr, page-13
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACR (ASX) to my watchlist
|
|||||
Last
5.8¢ |
Change
0.003(5.45%) |
Mkt cap ! $16.86M |
Open | High | Low | Value | Volume |
5.5¢ | 5.8¢ | 5.4¢ | $73.70K | 1.303M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 76865 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.8¢ | 101900 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 76865 | 0.056 |
1 | 35350 | 0.055 |
1 | 16012 | 0.054 |
1 | 18800 | 0.053 |
1 | 16012 | 0.052 |
Price($) | Vol. | No. |
---|---|---|
0.058 | 101900 | 2 |
0.059 | 225945 | 1 |
0.060 | 115000 | 1 |
0.061 | 100000 | 1 |
0.062 | 116100 | 2 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |